Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification.
(65/134)
(+info)
Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function.
(66/134)
(+info)
CD36 as a target to prevent cardiac lipotoxicity and insulin resistance.
(67/134)
(+info)
Disruption of TRPV1-mediated coupling of coronary blood flow to cardiac metabolism in diabetic mice: role of nitric oxide and BK channels.
(68/134)
(+info)
Diabetic cardiomyopathy: myth or reality?
(69/134)
(+info)
Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
(70/134)
(+info)
Cardioprotective effect of sodium ferulate in diabetic rats.
(71/134)
(+info)
Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.
(72/134)
(+info)